Gene · 4973
Papers4,129
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,129
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors. | Front Immunol | 2022 | 36713375 | PubTator, text mining | PubMed |
| Nitrogen-Doped Carbon Nanotube Cups for Cancer Therapy. | ACS Appl Nano Mater | 2022 | 36711215 | PubTator, text mining | PubMed |
| Methods on LDL particle isolation, characterization, and component fractionation for the development of novel specific oxidized LDL status markers for atherosclerotic disease risk assessment. | Front Med (Lausanne) | 2022 | 36687450 | PubTator, text mining | PubMed |
| Macrophage scavenger receptors: Tumor support and tumor inhibition. | Front Oncol | 2022 | 36686729 | PubTator, text mining | PubMed |
| The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer. | Biomolecules | 2022 | 36671447 | PubTator, text mining | PubMed |
| Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC - A systematic review. | Front Oncol | 2022 | 36620544 | PubTator, text mining | PubMed |
| New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter? | Int J Mol Sci | 2022 | 36613878 | PubTator, text mining | PubMed |
| Malondialdehyde as an Important Key Factor of Molecular Mechanisms of Vascular Wall Damage under Heart Diseases Development. | Int J Mol Sci | 2022 | 36613568 | PubTator, text mining | PubMed |
| Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia. | Int J Mol Sci | 2022 | 36613514 | PubTator, text mining | PubMed |
| Cell Dome as an Evaluation Platform for Organized HepG2 Cells. | Cells | 2022 | 36611862 | PubTator, text mining | PubMed |
| LOX-1 attenuates high glucose-induced autophagy via AMPK/HNF4α signaling in HLSECs. | Heliyon | 2022 | 36590506 | PubTator, text mining | PubMed |
| The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker. | Aging (Albany NY) | 2022 | 36585927 | PubTator, text mining | PubMed |
| The role of the sirtuin family in cartilage and osteoarthritis: molecular mechanisms and therapeutic targets. | Arthritis Res Ther | 2022 | 36585687 | PubTator, text mining | PubMed |
| Renal vein thrombosis after COVID-19: A case report. | Clin Case Rep | 2022 | 36583196 | PubTator, text mining | PubMed |
| The sirtuin family in health and disease. | Signal Transduct Target Ther | 2022 | 36581622 | PubTator, text mining | PubMed |
| Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes. | Front Genet | 2022 | 36579330 | PubTator, text mining | PubMed |
| Effect of repeated bolus and continuous glucose infusion on a panel of circulating biomarkers in healthy volunteers. | PLoS One | 2022 | 36574434 | PubTator, text mining | PubMed |
| Editorial: Immunotherapy for NSCLC with oncogenic driver variants. | Front Oncol | 2022 | 36568249 | PubTator, text mining | PubMed |
| Pharmacological Activities of Ginkgolic Acids in Relation to Autophagy. | Pharmaceuticals (Basel) | 2022 | 36558920 | PubTator, text mining | PubMed |
| Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics. | Molecules | 2022 | 36557840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/papers?page=38